H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. Census population 542,107. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Fresno clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Fresno storefront.
Chronic Wound Treatment That Works in Fresno, CA for clinics & physicians. Effective chronic wound treatme… Compliance support & pricing — contact Hawk Medical.
15.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. Population 542,107. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JE documentation are ready before the first application of chronic wound treatment.
National Chronic Wound Treatment That Works notes (how the product actually works)Three grains, kept separate on purpose. City: Census 542,107 and CDC PLACES crude rates. State: California Department of Public Health, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and Noridian Healthcare Solutions LCDs. CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Fresno trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 12.7% of adults — 0.7 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 21.2%. That is place-level BRFSS modeling, not a clinic census and not a Fresno trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a California compliance risk.
No. areaServed names the city we will ship to. It is not a claim that Hawk Medical is a Fresno medical practice or that we hold a local facility license.
California is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
Bring specialty, monthly wound volume, and whether you bill JE FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 12.7% diabetes and 21.2% arthritis for Fresno — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Fresno, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Fresno is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Fresno — 0.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Fresno. Useful for joint-program math; still needs a diagnosis and privileging.
No Fresno storefront. Joe Bradley is an active practice owner. chronic wound treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.